Old and New Players in Oral Antiplatelet Therapy in Treatment of Acute Coronary Syndrome

Nepal Journal of Medical Sciences
doi 10.3126/njms.v1i1.5799
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Nepal Journals Online (JOL)

Related search

Antiplatelet Therapy in Acute Coronary Syndrome

Continuing Cardiology Education
2017English

The Underutilisation of Dual Antiplatelet Therapy in Acute Coronary Syndrome

International Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2019English

Antiplatelet Treatment in Acute Coronary Syndrome Patients: Real-World Data From the START-Antiplatelet Italian Registry

PLoS ONE
Multidisciplinary
2019English

Ticagrelor: An Investigational Oral Antiplatelet Treatment for Reduction of Major Adverse Cardiac Events in Patients With Acute Coronary Syndrome

Vascular Health and Risk Management
2010English

S New Oral Anticoagulants – Will They Be Used With Antiplatelet Drugs in Patients With Atrial Fibrillation After Acute Coronary Syndrome?

Postepy w Kardiologii Interwencyjnej
Cardiovascular MedicineCardiology
2013English

Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies in Acute Coronary Syndrome

Annals of Internal Medicine
Internal MedicineMedicine
2014English

Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery Disease, and Peripheral Arterial Disease

JAMA - Journal of the American Medical Association
Medicine
2004English

Factors Associated With Platelet Reactivity During Dual Antiplatelet Therapy in Patients With Diabetes After Acute Coronary Syndrome

Scientific Reports
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy